Benzinga | Sep 20, 2021 06:04AM EDT

HSBC Initiates Coverage On Ginkgo Bioworks Holdings with Buy Rating, Announces Price Target of $14

HSBC analyst Sriharsha Pappu initiates coverage on Ginkgo Bioworks Holdings (NYSE:DNA) with a Buy rating and announces Price Target of $14.